Reapplix
PrivateLast Round
Series B
Jul 14, 2020
Total Funding Raised
$22.6M
Company Overview
Reapplix is a regenerative medicine company that develops and manufactures the 3C Patch System, an innovative biological wound therapy for the treatment of hard-to-heal diabetic foot ulcers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reapplix Comparables
Compare Reapplix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedDress | 90% | |
| Velora Wound Care | 85% | |
| Nuo Therapeutics Inc | 82% |
Reapplix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 14, 2020 | ||||
| VC Round | Sep 27, 2016 |
Key People
Founding team and executive leadership
Reapplix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lauxera Capital Partners | Series B |
| Novo Holdings | Series B |
| SEED Capital | VC Round |
| North-East Health Care Investment ApS | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2020
$23M round with participation from Novo Holdings and Lauxera Capital Partners.
- Sep 27, 2016
$3M round led by Novo Holdings and SEED Capital.
Reapplix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reapplix's valuation, stock price, and market status.
Is Reapplix a public or private company?
Reapplix is a private company.
What is the current stock price of Reapplix?
Reapplix is a private company with no public stock price. No recent secondary market data is available.
How much is Reapplix worth (valuation)?
Valuation information for Reapplix is not publicly available.
Can I buy Reapplix stock?
Reapplix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Reapplix's last funding round?
Reapplix's most recent funding round was Series B on July 14, 2020.
Who are the main investors in Reapplix?
Key investors in Reapplix include Lauxera Capital Partners, Novo Holdings, SEED Capital, North-East Health Care Investment ApS.
Will Reapplix IPO soon?
No public IPO plans have been announced for Reapplix.
How can I track Reapplix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reapplix's secondary market activity and sign up for updates.